News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Curis, Inc. (CRIS) Announces Appointment of Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations



5/31/2013 9:26:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., May 31, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced the appointment of Dr. Mani Mohindru as Vice President of Corporate Strategy and Investor Relations. In this role, Dr. Mohindru will leverage her expertise and experience to support the development and execution of corporate strategy and provide key leadership roles in Curis' product strategy, corporate development, investor relations and corporate communications.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES